[Prevention of some Ethionine-induced liver alterations in rats by silmarine (author's transl)].
D000438:Alcohols / Q000627:therapeutic use; D000818:Animals; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control; D005001:Ethionine / Q000506:poisoning*; D005234:Fatty Liver / Q000139:chemically induced* / Q000473:pathology / Q000517:prevention & control; D005260:Female; D005419:Flavonoids / Q000627:therapeutic use*; D066298:In Vitro Techniques; D007274:Injections, Intraperitoneal; D050356:Lipid Metabolism; D008099:Liver / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008112:Liver Glycogen / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects*; D051381:Rats
D000438:Alcohols; D005419:Flavonoids; D008112:Liver Glycogen; D005001:Ethionine
Prevención con silimarina de las alteraciones hepáticas inducidas con etionina en ratas.